InvestorsHub Logo
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

Re: biotech_researcher post# 12881

Monday, 09/26/2011 1:59:20 PM

Monday, September 26, 2011 1:59:20 PM

Post# of 80490
Too bad the timing sucks. The overall is filled with way too many unknowns for anyone to be committing any significant long money at this point, IMO.

I just wonder if a Ponatnib approval isn't close to being baked in the cake in this "new normal" (i.e. lack of risk appetite). Having the poster child for fledgling biotechs (DNDN) fall flat on it's face has certainly not helped matters.

BTW, the first line CML as well as 113 are two complete unknowns at this time. They could end up being huge home runs, but you are going to have to sit around and wait for their stories to develop.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.